InvestorsHub Logo
Followers 27
Posts 887
Boards Moderated 0
Alias Born 12/27/2013

Re: Canoepaddler post# 444

Tuesday, 10/18/2016 10:30:41 AM

Tuesday, October 18, 2016 10:30:41 AM

Post# of 853
Yes it's a "standard phase 1- single-ascending and multiple-ascending dose in healthy volunteers. The oral SCY-078 was more historically advanced than the IV formulation. This phase 1 trial serves as a required validation of our IV formulation so we can move forward in all subsequent studies with both IV + oral SCY-078." This is the exact message I received from the CFO. So with that said I expect nothing but success in this trial and furthermore I see them partnering soon for Europe.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SCYX News